The intestinal microbiota has been identified as an environmental factor that markedly affects energy storage and body-fat accumulation in mammals, yet the underlying mechanisms remain unclear. Here we show that the microbiota regulates body composition through the circadian transcription factor NFIL3. Nfil3 transcription oscillates diurnally in intestinal epithelial cells, and the amplitude of the circadian oscillation is controlled by the microbiota through group 3 innate lymphoid cells, STAT3 (signal transducer and activator of transcription 3), and the epithelial cell circadian clock. NFIL3 controls expression of a circadian lipid metabolic program and regulates lipid absorption and export in intestinal epithelial cells. These findings provide mechanistic insight into how the intestinal microbiota regulates body composition and establish NFIL3 as an essential molecular link among the microbiota, the circadian clock, and host metabolism.
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T he worldwide obesity epidemic presents a pressing public health crisis. More than 2.1 billion individuals throughout the world are overweight or obese, and~3.4 million deaths per year are caused by obesityrelated diseases (1) . Consequently, there is an urgent need to identify host and environmental factors that regulate human metabolism and energy homeostasis.
The intestinal microbiota is an environmental factor that markedly affects mammalian body composition. The microbiota promotes energy storage in adipose tissue, and thus microbiologically sterile (germ-free) mice have less body fat relative to conventionally raised mice (2) . This is because, in part, the microbiota enhance energy harvest from the host diet (3) and promote storage of that energy in adipose tissue (2) . Less is known about how microbial regulation of host metabolic pathways might also affect energy storage and body composition.
Many host metabolic pathways are synchronized with day-night light cycles through the circadian clock. The mammalian circadian clock is a network of transcription factors, present in all cells of the body, that drives rhythmic~24-hour oscillations in gene expression. Synchronization of metabolism with the clock couples energetically expensive metabolic pathways to the availability of dietary substrates, optimizing energy utilization. Emerging evidence indicates that the microbiota interacts with the circadian clock in ways that profoundly affect host metabolism and that disrupting these interactions can lead to obesity and other metabolic diseases (4, 5) . However, little is known about the mechanisms that govern microbiota interactions with the circadian clock and how these interactions alter host metabolism.
NFIL3, also known as E4BP4, is a basic leucine zipper transcription factor that is expressed in a variety of immune cells and controls immune functions that vary by cell type (6, 7) . We found that small intestinal epithelial cells also expressed NFIL3 and that expression was markedly reduced in germ-free mice (Fig. 1A ). This accorded with earlier findings in antibiotic-treated mice (8) and suggested that epithelial NFIL3 might regulate a physiological activity that is responsive to the intestinal microbiota.
To identify the physiological functions of NFIL3 in intestinal epithelial cells, we generated an antibiotics after switching to a HFD. All data represent two independent experiments with four to eight mice per group. Male mice were used in all experiments. Means ± SEM (error bars) are plotted; statistics were performed with Student's t test or one-way analysis of variance (ANOVA). *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant. epithelial cell-specific Nfil3 knockout mouse (Nfil3 DIEC ). Nfil3 DIEC mice raised on a chow diet weighed less than their Nfil3 f l/f l littermates (Fig. 1B and fig. S1A ) and had reduced body fat and increased lean body mass relative to Nfil3 f l/f l littermates ( fig. S1 , B and C). The body composition differences were not due to off-target effects of CRE expression (fig. S1, D and E) or differences in food intake ( fig. S2A ), physical activity ( fig.  S2B ), or energy utilization ( fig. S3 , A to C), which were similar between the two groups. We also did not detect differences in the response to intestinal injury ( fig. S4, A to D) or in the expression of key inflammatory cytokines and antimicrobial proteins ( fig. S5, A to E) .
When placed on a high-fat, Western-style diet (HFD) for 10 weeks, both Nfil3 fl/fl and Nfil3 DIEC mice gained weight (Fig. 1B) . However, the Nfil3 DIEC mice maintained lower body weights ( Fig. 1B) and had lower body-fat percentages (Fig. 1C ) and higher lean-body-mass percentages ( fig. S6A ). The Nfil3 DIEC mice also had lower epididymal fat-pad weights ( Fig. 1D and fig. S6B ) and were protected from elevated blood triglycerides (Fig. 1E) , liver-fat accumulation (Fig. 1F) , lowered glucose tolerance (Fig. 1G) , and increased insulin resistance (Fig. 1G ). 16S ribosomal RNA gene sequencing of fecal microbiotas indicated that the metabolic differences between Nfil3 fl/fl and Nfil3 DIEC mice were not due to differences in microbiota taxonomic composition ( fig. S7 ). Thus, epithelial NFIL3 regulates lipid storage and body composition in mice.
Because epithelial NFIL3 expression is dependent on the microbiota, we sought to determine whether NFIL3-dependent body-fat accumulation also depends on the microbiota. Depletion of the microbiota through antibiotic treatment produced lower fat and higher lean body mass in the Nfil3 f l/fl mice, resulting in body compositions that were not significantly different from those of Nfil3 DIEC mice (Fig. 1H and fig. S8 ). Thus, HFD-induced body-fat accumulation requires both NFIL3 and a microbiota.
We next studied the mechanism by which the microbiota regulates NFIL3 expression. Nfil3 transcription is controlled by the circadian clock (9); accordingly, Nfil3 transcript abundance oscillated diurnally in an enriched population of small intestinal epithelial cells acquired by laser capture microdissection ( Fig. 2A) . Comparison of Nfil3 expression levels across a circadian cycle in wild-type germ-free and conventional mice revealed that the microbiota is required for maximal Nfil3 expression and thus governs the amplitude of Nfil3 transcriptional rhythms ( Fig. 2A) . This was reflected in protein expression levels (Fig. 2B ) and accords with earlier findings in antibiotictreated mice (8) .
Nfil3 expression is directly regulated by the core circadian clock transcriptional repressor REV-ERBa. In T cells and liver cells, REV-ERBa binds to a consensus sequence in the Nfil3 gene locus and represses transcription, resulting in a rhythmic diurnal Nfil3 expression pattern (6, 10). Rev-erba transcript and protein abundance also oscillated diurnally in intestinal epithelial cells but was higher in germ-free mice versus conventional mice (Fig. 2, C and D) . This suggested that REV-ERBa governs circadian rhythmicity in Nfil3 expression and that the microbiota might induce Nfil3 expression by repressing Rev-erba expression. REV-ERBa bound directly to the Nfil3 promoter in intestinal epithelial cells, as assessed by chromatin immunoprecipitation (ChIP) assay (Fig. 2E) . Further, Nfil3 expression in antibiotic-treated Rev-erba −/− mice was similar to that in conventional wild-type mice (Fig. 2F) . Thus, microbiota regulation of Nfil3 expression is REV-ERBa-dependent, and the microbiota elevates Nfil3 expression by repressing Rev-erba expression.
We next sought to determine how bacterial signals are relayed to the epithelial circadian clock to regulate Rev-erba and Nfil3 expression. Intestinal epithelial cells sense the microbiota through Toll-like receptors (TLRs) and their common signaling adaptor MyD88 to regulate the expression of key genes (11) . We therefore tested whether MyD88 is required for microbiota regulation of Rev-erba and Nfil3 expression in epithelial cells. We quantified Rev-erba and Nfil3 transcripts in epithelial cells from Myd88 −/− mice and wild-type littermates at Zeitgeber time 4 (ZT4), which is when Nfil3 expression is nearpeak in conventional mice ( Fig. 2A) . Epithelial Rev-erba expression was increased and Nfil3 expression was consequently reduced to germ-free levels in Myd88 −/− mice (Fig. 2G) , indicating that microbiota regulation of the Rev-erba-Nfil3 cascade requires MyD88. Whereas epithelial MyD88 was dispensable for microbiota-induced alterations in Rev-erba and Nfil3 expression, Myd88 expression in a CD11c + cell population (which includes some dendritic cells) was required for maximal repression of Rev-erba and induction of Nfil3 (Fig. 2G) , suggesting a requirement for dendritic cells (DCs).
To further test for DC involvement, we used a mouse model of DC depletion in which Diphtheria toxin receptor (DTR) is expressed under the control of the Cd11c promoter (12) . On administration of Diphtheria toxin, CD11c + cells are selectively killed (12) . On CD11c + cell depletion, Rev-erba expression was increased and Nfil3 expression was decreased (Fig. 2H) , supporting a requirement for DCs in microbiota induction of Nfil3.
Previous studies have identified a subepithelial cellular signaling relay in the small intestine that captures microbiota signals and passes them to epithelial cells to alter expression of key epithelial cell genes (13, 14) . In this circuit, bacteria activate TLR-MyD88 signaling in DCs, and the bacterial signals are relayed from DC to group 3 innate lymphoid cells (ILC3) through the cytokine interleukin-23 (IL-23). ILC3 then signal to the epithelium through the production of IL-22 (15) .
To determine whether ILCs were required for microbiota-induced Nfil3 expression, we studied ID2-deficient mice (Id2 g fp/g fp ), which lack all known ILC subsets (16, 17) . Id2 gfp/gfp mice showed increased Rev-erba expression and consequent decreased Nfil3 expression in the small intestinal epithelium (Fig. 2H) , consistent with a requirement for ILCs in regulating Rev-erba expression. Rag1 −/− mice, which lack T and B cells, showed decreased epithelial Rev-erba expression and increased Nfil3 expression (Fig. 2H) . The fact that Nfil3 expression was higher in Rag1 −/− mice than in conventional wild-type mice is likely due to the elevated bacterial loads as well as aberrant expansion of ILC3 in the small intestines of these mice (18) Means ± SEM (error bars) are plotted; statistics were performed with Student's t test or one-way ANOVA. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.
(19), which lack both T helper 17 cells and ILC3, showed circadian Rev-erba and Nfil3 expression patterns (Fig. 2, I and J) that were similar to those of germ-free mice (Fig. 2, A and B) . This establishes that ILC3 are required for microbiota induction of Nfil3 expression through Rev-erba. Treatment of Myd88 −/− mice with recombinant IL-23 or IL-22 restored epithelial Rev-erba and Nfil3 expression to wild-type conventional levels (Fig. 2K) , further supporting the idea that the subepithelial DC-ILC3 circuit relays microbiota signals to epithelial cells to regulate Nfil3 expression.
The intestinal DC-ILC3 circuit can be triggered by flagellin or lipopolysaccharide (LPS), which is present in the outer membranes of Gramnegative bacteria (20, 21) . Accordingly, treatment of germ-free mice with flagellin and LPS decreased Rev-erba expression and increased Nfil3 expression ( fig. S9, A and B) . Further, Rev-erba expression decreased and Nfil3 expression increased when we monoassociated germ-free mice with Gram-negative, flagellated bacterial species, including Salmonella typhimurium and Escherichia coli ( fig. S9, A and B) . Rev-erba and Nfil3 expression were not markedly altered by monoassociation with the Gram-positive species Enterococcus faecalis or with the Gram-negative nonflagellated species Bacteroides thetaiotaomicron, suggesting that Nfil3 expression is selectively activated by Gramnegative, motile bacteria. This is likely because such bacteria produce both flagellin and LPS and because they can readily penetrate the intestinal epithelial barrier and contact lamina propria DCs.
We next sought to identify epithelial cellintrinsic pathways downstream of IL-22 that regulate Rev-erba and Nfil3 expression. The transcription factor STAT3 (signal transducer and activator of transcription 3) is a key response element downstream of the IL-22 receptor (IL-22R) (14) . Activation of the IL-22R leads to phosphorylation of STAT3, which then binds to the promoters of its target genes and either activates or inhibits their transcription. ChIP analysis of intestinal epithelial cells showed STAT3 binding to the Rev-erba promoter (Fig. 3, A and B) . STAT3 binding was markedly reduced in epithelial cells from germ-free mice (Fig. 3, A and B) . Cotransfection of STAT3-encoding vectors with luciferase reporters fused to the Rev-erba promoter resulted in decreased luciferase activity in human embryonic kidney-293 T (HEK-293T) cells (Fig.  3C) , and expression of a dominant active form of STAT3 further inhibited the luciferase activity (Fig. 3C) . Thus, STAT3 binds to the Rev-erba promoter and inhibits its transcription. We used cultured intestinal organoids to further evaluate the role of STAT3 in repressing Rev-erba transcription. Addition of recombinant IL-22 to organoid cultures resulted in STAT3 phosphorylation (Fig. 3D) , supporting earlier findings that IL-22 activates STAT3 in intestinal epithelial cells (14) . At the same time, expression of Rev-erba was decreased and expression of Nfil3 was increased as compared with controls (Fig. 3, E and F) . In contrast, when we added a STAT3 phosphorylation inhibitor (Stattic) (22) to organoids, together with recombinant IL-22, STAT3 phosphorylation was inhibited (Fig. 3D) , and Rev-erba and Nfil3 showed expression levels similar to those of the controls (Fig. 3,  E and F) . These findings further support the idea that STAT3 is a transcriptional repressor of Rev-erba.
We next investigated whether STAT3 is required for microbiota repression of epithelial Rev-erba expression in vivo. We generated a mouse with an epithelial cell-specific deletion of Stat3 (Stat3 DIEC ) and assayed for Rev-erba and Nfil3 expression in intestinal epithelial cells. Consistent with our in vitro findings, the Stat3 DIEC mice showed increased expression of epithelial Rev-erba and decreased expression of Nfil3 as compared with their Stat3 f l/f l littermates (Fig. 3, G and H) . The expression of Stat3 and the activation of STAT3 in intestinal epithelial cells did not exhibit diurnal rhythms ( fig. S10, A and B) , indicating that STAT3 does not generate the rhythmicity in Rev-erba and Nfil3 expression. Instead, our findings suggest that diurnal rhythms in NFIL3 expression are generated by the circadian clock through REV-ERBa, whereas the amplitude of these rhythms is fine-tuned by the microbiota through STAT3.
To understand the mechanism by which epithelial NFIL3 regulates fat storage and body composition, we compared the transcriptomes of epithelial cells from Nfil3 f l/f l and Nfil3 DIEC mice. We performed an RNA sequencing analysis on intestinal epithelial cells at multiple time points across the 24-hour day-night light cycle. We identified 33 transcripts that have differential abundances in Nfil3 fl/fl and Nfil3 DIEC mice, noting that expression of a number of these genes was diurnally rhythmic in Nfil3 f l/f l mice (Fig. 4A ). Rhythmic expression of the clock genes Bmal1 (Arnt1), Per2, and Nr1d1 (Rev-erba) was maintained in Nfil3 DIEC mice (Fig. 4A) , indicating that the core clock mechanism remains intact. Seventeen of the transcripts encoded proteins that are known to function in lipid uptake and metabolism (Fig. 4A) . These included Cd36, encoding a transporter that imports dietary fatty acids into cells (23) ; Scd1, encoding a stearoyl-coenzyme A-desaturase 1 (24); Cyp2e1, encoding a fatty acid hydroxylase (25) ; and Fabp4, encoding a fatty acid binding protein (26) . Deletion of each of these genes protects against HFD-induced obesity and/or insulin resistance (24) (25) (26) (27) , suggesting that their lowered expression in Nfil3 DIEC mice could partially account for the metabolic phenotypes of these mice. We further analyzed Cd36 and Scd1 transcripts by quantitative real-time polymerase chain reaction (qRT-PCR), confirming that expression of both genes required epithelial NFIL3 and the microbiota (Fig. 4B) . Western blot analysis confirmed that CD36 protein levels were reduced in germ-free and Nfil3 DIEC mice (Fig. 4C) . Additionally, expression of Cd36 and Scd1 was reduced in Id2 gfp/gfp and Stat3 DIEC mice (Fig. 4, D and E) , consistent with microbiota regulation of Nfil3 expression through ILC and epithelial STAT3. Thus, the microbiota regulates an NFIL3-dependent lipid metabolic program that is intrinsic to intestinal epithelial cells.
These findings accord with the key functions of intestinal epithelial cells in fatty acid uptake and metabolism. After absorption by enterocytes, fatty acids are processed and packaged into chylomicrons for export into the circulation. These processes show circadian rhythmicity, which results in diurnal variations in circulating lipids (28) . Additionally, disruption of rhythms in chylomicron export, as seen in mice lacking nocturnin, is also associated with a lean phenotype (29) . Thus, we hypothesized that the metabolic phenotypes of Nfil3 DIEC mice might arise from reduced epithelial cell uptake and processing of dietary lipids with consequent lowered export of lipids to the circulation for storage in adipose tissue.
We tested this idea by visualizing lipid stores in small intestinal tissues from HFD-fed Nfil3 DIEC and Nfil3 fl/fl mice. Lipids were detected by staining small intestinal sections with Oil Red O, which revealed that the intestinal epithelial cells of Nfil3 f l/f l mice harbor abundant lipids (Fig. 4F ). By contrast, lipids were less abundant in intestinal epithelial cells from Nfil3 DIEC mice (Fig. 4F ).
Nfil3
DIEC mice also showed reduced Oil Red O staining in subepithelial intestinal tissues, suggesting reduced export of lipids into the lymphatic capillaries that transport packaged lipids to the bloodstream ( fig. S11 ). Consistent with these findings, lipid concentrations were also lower in intestinal epithelial cells (Fig. 4G ) but higher in feces (Fig. 4H) Here we have shown that NFIL3 is an essential molecular link among the microbiota, the circadian clock, and host metabolism. Our findings indicate that the microbiota acts through NFIL3 to regulate lipid uptake and storage, thus providing insight into how the intestinal microbiota regulates host metabolism and body composition. Further, we have shown that the ILC3-STAT3 signaling relay forms an essential conduit between the microbiota and the epithelial circadian clock, thus identifying key molecular circuitry through which the microbiota interacts with the clock (fig. S12) . These results potentially provide a deeper understanding of why perturbing microbiota-clock interactions can lead to metabolic disease (4, 5) . Our studies could also help to explain why circadian clock disruptions in humans, arising from shift work or international travel, are associated with an increased occurrence of metabolic diseases, including obesity, diabetes, and cardiovascular disease (30, 31) . Ultimately, our findings could lead to new strategies for treating metabolic disease by targeting NFIL3, STAT3, the microbiota, or the circadian clock.
